SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by van Leuven, S I
Right arrow Articles by Stroes, E S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Leuven, S I
Right arrow Articles by Stroes, E S
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Joint Disorders
*Lupus
*Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Atherogenesis in rheumatology

S I van Leuven

Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

J JP Kastelein

Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

D P D’Cruz

Lupus Research Unit, Rayne Institute, St Thomas’ Hospital, London, UK

G R Hughes

Lupus Research Unit, Rayne Institute, St Thomas’ Hospital, London, UK

E S Stroes

Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands, E.S.Stroes{at}amc.uva.nl

Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). In addition to systemic inflammation, additional mechanisms have been put forward that are more specific for the pathophysiology of the individual chronic inflammatory disorders.

Key Words: APS • atherogenesis • inflammation • RA • SLE

Lupus, Vol. 15, No. 3, 117-121 (2006)
DOI: 10.1191/0961203306lu2273rr
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
S. I. van Leuven, R. Hezemans, J. H. Levels, S. Snoek, P. C. Stokkers, G. K. Hovingh, J. J. P. Kastelein, E. S. Stroes, E. de Groot, and D. W. Hommes
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
J. Lipid Res., December 1, 2007; 48(12): 2640 - 2646.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
A. Aviv, A. M Valdes, and T. D Spector
Human telomere biology: pitfalls of moving from the laboratory to epidemiology
Int. J. Epidemiol., December 1, 2006; 35(6): 1424 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
G R V Hughes and H Phillips
Mycophenolate mofetil and cardiovascular disease
Lupus, November 1, 2006; 15(11_suppl): 1 - 2.
[Abstract] [PDF]


Advertisement